Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration

por Schiff, Michael, Weinblatt, Michael E, Valente, Robert, Citera, Gustavo, Maldonado, Michael, Massarotti, Elena, Yazici, Yusuf, Fleischmann, Roy
Publicado 2016

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

por Weinblatt, Michael E, Schiff, Michael, Valente, Robert, van der Heijde, Désirée, Citera, Gustavo, Zhao, Cathy, Maldonado, Michael, Fleischmann, Roy
Publicado 2013

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

por Schiff, Michael, Weinblatt, Michael E, Valente, Robert, van der Heijde, Désirée, Citera, Gustavo, Elegbe, Ayanbola, Maldonado, Michael, Fleischmann, Roy
Publicado 2014

Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1

por Valente, Robert M., Ehlers, Erica, Xu, Dongsheng, Ahmad, Humera, Steadman, Andrew, Blasnitz, Laura, Zhou, You, Kastanek, Lisa, Meng, Bin, Zhang, Luwen
Publicado 2012